DEXCOM INC — Investor Relations & Filings

Dexcom Inc. is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems for diabetes management. The company's core technology consists of wearable sensors that continuously measure and transmit glucose levels to a compatible smart device or receiver, providing real-time data, alerts, and trend information. Its product portfolio, which includes the Dexcom G6, G7, and the over-the-counter Stelo Glucose Biosensor System, is designed to help people with diabetes make treatment decisions without traditional fingersticks. The systems also assist users in understanding how lifestyle factors like diet and exercise impact their glucose levels, empowering them to take greater control of their health.